nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Developer’s Perspective on Clinical Evidence and Benefits for Rituximab Biosimilar Uptake, with a Focus on CT-P10
|
Choi, Dasom |
|
|
42 |
4 |
p. 285-300 |
artikel |
2 |
Atogepant for Migraine Prevention: A Systematic Review of Efficacy and Safety
|
Singh, Alok |
|
|
42 |
4 |
p. 301-308 |
artikel |
3 |
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany
|
Rivero-Ferrer, Elena |
|
|
42 |
4 |
p. 319-331 |
artikel |
4 |
Comparison of Warfarin Initiation at 3 mg Versus 5 mg for Anticoagulation of Patients with Mechanical Mitral Valve Replacement Surgery: A Prospective Randomized Trial
|
Sabry, Sarah |
|
|
42 |
4 |
p. 309-318 |
artikel |
5 |
Correction to: The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]‑BI 425809 in Healthy Males
|
Burkard, Ute |
|
|
42 |
4 |
p. 375 |
artikel |
6 |
Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
|
Michaeli, Daniel Tobias |
|
|
42 |
4 |
p. 333-343 |
artikel |
7 |
Estimation Model for Healthcare Costs and Intensive Care Units Access for Covid-19 Patients and Evaluation of the Effects of Remdesivir in the Portuguese Context: Hypothetical Study
|
Ruggeri, Matteo |
|
|
42 |
4 |
p. 345-354 |
artikel |
8 |
Multiple Sclerosis Relapses Following Cessation of Fingolimod
|
Malpas, Charles B. |
|
|
42 |
4 |
p. 355-364 |
artikel |
9 |
Tralokinumab in Atopic Dermatitis: A Profile of Its Use
|
Blair, Hannah A. |
|
|
42 |
4 |
p. 365-374 |
artikel |